Ufp Technologies (UFPT) Other Non-Current Assets (2010 - 2026)
Ufp Technologies (UFPT) posted Other Non-Current Assets of $5.3 million for Q1 2026, up 53.19% on a QoQ basis from $3.4 million in Q4 2025, and up 52.97% year-over-year from $3.4 million in Q1 2025.
Ufp Technologies (UFPT) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Ufp Technologies' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $5.3 million for Q1 2026.
- Quarterly Other Non-Current Assets rose 52.97% year-over-year to $5.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.3 million (up 52.97% YoY) and the FY2025 annual result came in at $3.4 million, up 670.47% from the prior year.
- Other Non-Current Assets was $5.3 million for Q1 2026 at Ufp Technologies, up from $3.4 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $5.3 million in Q1 2026 and bottomed at $413000.0 in Q1 2024.
- A 5-year average of $2.1 million and a median of $1.2 million in 2022 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets surged 1813.07% — and 2024, when it tumbled 88.42%.
- Ufp Technologies' Other Non-Current Assets stood at $3.6 million in 2022, then slumped by 87.1% to $469000.0 in 2023, then retreated by 4.69% to $447000.0 in 2024, then soared by 670.47% to $3.4 million in 2025, then jumped by 53.19% to $5.3 million in 2026.
- Business Quant data shows UFPT's Other Non-Current Assets at $5.3 million in Q1 2026, $3.4 million in Q4 2025, and $3.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | Ufp Technologies | 1.82 Bn | 1.80 Bn | 44.36 Mn | 5.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.28 Mn |
| Dec 31, 2025 | 3.44 Mn |
| Sep 30, 2025 | 3.47 Mn |
| Jun 30, 2025 | 3.45 Mn |
| Mar 31, 2025 | 3.45 Mn |
| Dec 31, 2024 | 447,000.00 |
| Sep 30, 2024 | 436,000.00 |
| Jun 30, 2024 | 414,000.00 |
| Mar 31, 2024 | 413,000.00 |
| Dec 31, 2023 | 469,000.00 |
| Sep 30, 2023 | 633,000.00 |
| Jun 30, 2023 | 858,000.00 |
| Mar 31, 2023 | 3.57 Mn |
| Dec 31, 2022 | 3.64 Mn |
| Sep 30, 2022 | 3.81 Mn |
| Jun 30, 2022 | 1.13 Mn |
| Mar 31, 2022 | 1.17 Mn |
| Dec 31, 2021 | 1.10 Mn |
| Sep 30, 2021 | 199,000.00 |
| Jun 30, 2021 | 153,000.00 |